ES539987A0 - Un procedimiento para preparar un anticuerpo monoclonal hu- mano - Google Patents

Un procedimiento para preparar un anticuerpo monoclonal hu- mano

Info

Publication number
ES539987A0
ES539987A0 ES539987A ES539987A ES539987A0 ES 539987 A0 ES539987 A0 ES 539987A0 ES 539987 A ES539987 A ES 539987A ES 539987 A ES539987 A ES 539987A ES 539987 A0 ES539987 A0 ES 539987A0
Authority
ES
Spain
Prior art keywords
preparing
procedure
monoclonal antibody
monoclonal antibodies
human monoclonal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES539987A
Other languages
English (en)
Other versions
ES8802621A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Western Atlas Inc
Original Assignee
Litton Bionetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24300700&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES539987(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Litton Bionetics Inc filed Critical Litton Bionetics Inc
Publication of ES539987A0 publication Critical patent/ES539987A0/es
Publication of ES8802621A1 publication Critical patent/ES8802621A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES539987A 1984-01-31 1985-01-30 Un procedimiento para preparar un anticuerpo monoclonal hu- mano Expired ES8802621A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57553384A 1984-01-31 1984-01-31

Publications (2)

Publication Number Publication Date
ES539987A0 true ES539987A0 (es) 1988-09-16
ES8802621A1 ES8802621A1 (es) 1988-09-16

Family

ID=24300700

Family Applications (1)

Application Number Title Priority Date Filing Date
ES539987A Expired ES8802621A1 (es) 1984-01-31 1985-01-30 Un procedimiento para preparar un anticuerpo monoclonal hu- mano

Country Status (15)

Country Link
EP (1) EP0151030B1 (es)
JP (2) JPH0759518B2 (es)
AT (1) ATE71410T1 (es)
AU (2) AU589351B2 (es)
CA (1) CA1340781C (es)
DE (1) DE3585093D1 (es)
DK (1) DK171896B1 (es)
ES (1) ES8802621A1 (es)
GR (1) GR850179B (es)
HU (1) HU209519B (es)
IE (1) IE58859B1 (es)
IL (1) IL74156A (es)
NZ (1) NZ210867A (es)
PT (1) PT79894B (es)
ZA (1) ZA85689B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3319751A1 (de) * 1983-05-31 1984-12-06 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verfahren zur gewinnung von gegen tumorantigene gerichteten monoklonalen antikoerpern und diese enthaltende arzneimittel
US6294172B1 (en) 1983-08-12 2001-09-25 Dade Behring Marburg Gmbh Monoclonal antibodies with specificity for membrane-associated antigens
DE3629640A1 (de) * 1986-08-30 1988-03-03 Behringwerke Ag Verwendung monoklonaler antikoerper zur therapie von tumoren
US5011684A (en) * 1985-09-05 1991-04-30 Beth Israel Hospital Association Lysing or blocking unwanted cells with IL-2 receptor-specific binding substance
US5552291A (en) * 1985-10-09 1996-09-03 Kyowa, Hakko Kogyo Co., Ltd. Anti-human pulmonary adenocarcinoma specific monoclonal antibody
JPS6283898A (ja) * 1985-10-09 1987-04-17 Kyowa Hakko Kogyo Co Ltd 抗ヒト肺腺癌特異的単クロ−ン性抗体
EP0222360A3 (en) * 1985-11-12 1989-03-15 Biotherapeutics Inc. A method of producing a patient-specific cytotoxic reagent and composition
JPS62207298A (ja) * 1986-03-06 1987-09-11 Kyowa Hakko Kogyo Co Ltd 抗ヒト胃癌単クロ−ン性抗体
JPH06100843B2 (ja) * 1986-06-23 1994-12-12 キヤノン株式会社 絶縁性磁性乾式現像剤
EP0265156A3 (en) * 1986-10-14 1990-08-29 Bunge (Australia) Proprietary Limited Monoclonal antibodies
DK169987D0 (da) * 1987-04-03 1987-04-03 Jens Christian Jensenius Human tumor-associated antigen, ca-ou1
ATE137674T1 (de) * 1987-07-02 1996-05-15 Akzo Nobel Nv Von mca 16-88 erkanntes antigen
US5215913A (en) 1987-11-30 1993-06-01 Roger Williams General Hospital IgG-1 human monoclonal antibody reactive with an HIV-1 antigen and methods of use
DE3909799A1 (de) 1989-03-24 1990-09-27 Behringwerke Ag Monoklonale antikoerper (mak) gegen tumorassoziierte antigene, ihre herstellung und verwendung
CA2034484C (en) * 1989-06-19 2000-08-15 Maurits W. Geerlings Radioimmunotherapy using .alpha.-particles emission
DK0537168T3 (da) * 1990-04-12 1996-09-02 Akzo Nobel Nv Antigenet CTAA 28A32, som genkendes af MCA 28A32
CA2086531A1 (en) * 1990-07-03 1992-01-04 Ebo S. Bos Immunoreactive compound
US5281710A (en) * 1990-08-01 1994-01-25 The Scripps Research Institute Dynemicin analogs: synthesis, methods of preparation and use
CA2108767A1 (en) * 1991-05-16 1992-11-17 Michael G. Hanna, Jr. Tumor associated monoclonal antibody 81av78
IL103758A (en) * 1991-12-13 1998-07-15 Akzo Nv Tumor specific monoclonal antibodies
JPH06113831A (ja) * 1992-04-08 1994-04-26 Dev Center For Biotechnol ハイブリドーマおよびその抗体
EP0650735A3 (en) * 1993-07-09 1999-04-14 Akzo Nobel N.V. Kit and method for pretargeting
ATE421328T1 (de) 2002-02-22 2009-02-15 Intracel Recources Llc Sterile immunogene nicht-tumorigene tumorzell- zusammensetzungen und verfahren
US7176022B2 (en) 2002-12-20 2007-02-13 Cell Genesys, Inc. Directly injectable formulations which provide enhanced cryoprotection of cell products
EP3052933B1 (en) * 2013-10-02 2019-09-04 Suri Technologies Ltd. Patient-specific immunotherapy for treating heterogeneous tumors
EP3409297A1 (en) 2017-05-30 2018-12-05 AlfaRim Medial Holding B.V. The optimal 225actinium--213bismuth generator for alpha-particle radioimmunotherapy
WO2019057598A1 (en) 2017-09-20 2019-03-28 Alfarim Medical Holding B.V. OPTIMAL 225ACTINIUM - 213BISMUTH GENERATOR FOR ALPHA PARTICLE RADIO IMMUNOTHERAPY

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4322879A (en) * 1978-01-11 1979-07-19 Massachusetts General Hospital, The Producing antibodies
DE3211356A1 (de) * 1982-03-27 1983-09-29 Behringwerke Ag, 3550 Marburg Zell-hybrid, verfahren zu seiner herstellung sowie seine verwendung
JPS58201994A (ja) * 1982-05-21 1983-11-25 Hideaki Hagiwara 抗原特異的ヒト免疫グロブリンの生産方法
JPS59137497A (ja) * 1983-01-20 1984-08-07 ザ・リ−ジエンツ・オブ・ザ・ユニバ−シテイ・オブ・カリフオルニア 抗原特異的免疫グロブリン生産性ヒト／ヒトハイブリド−マ及びその生産する抗体
US4613576A (en) * 1983-03-09 1986-09-23 Sloan-Kettering Institute For Cancer Research Human monoclonal antibodies to cancer cells

Also Published As

Publication number Publication date
CA1340781C (en) 1999-10-12
IE850192L (en) 1985-07-31
NZ210867A (en) 1989-01-06
AU4736789A (en) 1990-05-03
EP0151030A2 (en) 1985-08-07
DK40885A (da) 1985-10-25
AU589351B2 (en) 1989-10-12
DK40885D0 (da) 1985-01-30
GR850179B (es) 1985-05-23
PT79894B (en) 1986-10-23
HUT36859A (en) 1985-10-28
AU635511B2 (en) 1993-03-25
EP0151030B1 (en) 1992-01-08
ATE71410T1 (de) 1992-01-15
JPH06315395A (ja) 1994-11-15
IE58859B1 (en) 1993-11-17
ES8802621A1 (es) 1988-09-16
IL74156A0 (en) 1985-04-30
HU209519B (en) 1994-06-28
JPS60260597A (ja) 1985-12-23
DE3585093D1 (de) 1992-02-20
JP2516731B2 (ja) 1996-07-24
IL74156A (en) 1990-08-31
DK171896B1 (da) 1997-08-04
AU3799285A (en) 1985-08-08
ZA85689B (en) 1986-04-30
EP0151030A3 (en) 1987-11-25
JPH0759518B2 (ja) 1995-06-28
PT79894A (en) 1985-02-01

Similar Documents

Publication Publication Date Title
AU589351B2 (en) Tumor specific monoclonal antibodies
DK164510C (da) Humant hybridom, humant monoklonalt antistof opnaaet derfra, anvendelse af et saadant antistof og fremgangsmaade til fremstilling af et saadant antistof
KR880700061A (ko) 인체 암종양과 관련된 항원에 대한 단클론성 항체
EP0220858A3 (en) Monoclonal anti-human breast cancer antibodies, corresponding hybridomas, the production and use thereof
ATE71225T1 (de) Verwendung eines spezifischen tumorassoziierten antigens, sialosyllactotetraose, in diagnoseoder therapieverfahren bezueglich krebskrankheiten.
DE68924983D1 (de) Anti-idiotyp antikörper induktion eines antitumorenresponses.
IL86958A (en) Human monoclonal antibody igm 16-88, cell lines producing it and antigen recognized thereby
EP0537168A4 (en) Ctaa 28a32, the antigen recognized by mca 28a32
EP0584267A4 (en) TUMOR-SPECIFIC MONOCLONAL ANTIBODY 81AV78.
Ferrone et al. Active Specific Immunotherapy of Malignant Melanoma with Anti‐idiotypic Monoclonal Antibodies
NO924803L (no) Tumor-relatert monoklonalt antistoff 88bv59
DE3784364D1 (de) Tumorassoziiertes antigen.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20040601